News &amp; Updates

Continuous dopamine D2 receptor blockade does not appear to increase the risk of breakthrough psychosis in patients with first-episode schizophrenia, as shown in a study.

Long-term D2 blockade not to blame for relapse in schizophrenia

OSA linked to arrhythmias during sleep in IHD patients

A significant association between obstructive sleep apnoea (OSA) and nocturnal atrial fibrillation (AF)/flutter has been observed in patients with ischaemic heart disease (IHD), reveals a Singapore study.

OSA linked to arrhythmias during sleep in IHD patients

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

Clinically relevant drug–drug interactions (DDIs) are highly prevalent among oncohematology patients treated with nirmatrelvir/ritonavir (NMV/r) for COVID-19, reveals a study. Pharmacists have played an important role in detecting, categorizing, and mitigating these DDIs.

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

Oral microbiota may identify autism in kids with >80 percent accuracy

Eleven oral bacterial species may serve as biomarkers for early detection of autism through simple oral sampling, with an accuracy of 81 percent, according to a cross-disciplinary research team from the Faculty of Dentistry and the Department of Psychology of the University of Hong Kong (HKU).

Oral microbiota may identify autism in kids with >80 percent accuracy

29 Apr 2025

Proteomic analysis identifies DKD progression markers in YT2D

A comprehensive analysis of circulating proteins identifies known and novel proteins associated with the progression of diabetic kidney disease (DKD) in Asians with younger-onset type 2 diabetes (YT2D; T2D onset age <40 years).

Proteomic analysis identifies DKD progression markers in YT2D

29 Apr 2025

Inebilizumab shows benefit in patients with gMG

Treatment with inebilizumab significantly improved generalized myasthenia gravis (gMG) symptoms, as shown by a greater reduction in MG-Activities of Daily Living (MG-ADL) scores, among patients who were acetylcholine receptor antibody-positive (AChR-Ab+) or muscle-specific kinase antibody-positive (MuSK-Ab+), according to the phase III MINT* trial presented at AAN 2025.

Inebilizumab shows benefit in patients with gMG

Community pharmacists ensure safe, effective use of OAMs

Community pharmacists (CPs) are willing to implement oral anticancer medicine (OAM) interventions, which can potentially improve the management of patients with cancer, according to a cross-sectional study in France.

Community pharmacists ensure safe, effective use of OAMs

Noodle intake linked to metabolic syndrome

28 Apr 2025 by

High noodle consumption may lead to the development of metabolic syndrome, according to a recent study involving Korean adults.

Noodle intake linked to metabolic syndrome

How aware are HCPs about medication errors in oncology practice?

The level of awareness regarding medication errors (MEs) is good to average among most healthcare professionals (HCPs) in a cancer hospital, reports a study.

How aware are HCPs about medication errors in oncology practice?